Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
The Lancet Diabetes & Endocrinology. Vol 3(5):356-66, May 2015 http://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00044-3/abstract
Leggi


